Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study

Autor: M. Guirado, H. Arasanz, Carlos Aguado, M. Provencio, E. Del Barco, J. Coves, Ana Laura Ortega Granados, Guillermo López Vivanco, Delvys Rodriguez-Abreu, M. Cobo, B. Massuti, A. C. Lorduy, Sergio Vazquez-Estevez, C. Lucia, Anna Estival, G. M. Serrano, Margarita Majem, B. J. Munarriz, O. Juan-Vidal

Publikováno v: JOURNAL OF CLINICAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

8531 Background: Coronavirus disease 2019 (COVID-19) is diagnosed by detecting the virus by reverse transcription polymerase chain reaction (RT-PCR). The majority of p go on to develop antibodies (Ab) against viral proteins. However, it is not known

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::815135d6d297db61f275032f3a99d322
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12204